Drisdol and Macrobid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Drisdol (ergocalciferol) and Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline). Common drug interactions include renal failure among females.

The phase IV clinical study analyzes what interactions people have when they take Drisdol and Macrobid. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Drisdol?

Drisdol has active ingredients of ergocalciferol. It is often used in vitamin d. eHealthMe is studying from 1,741 Drisdol users. Check the latest studies of Drisdol.

What is Macrobid?

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 9,215 Macrobid users. Check the latest studies of Macrobid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

15 people who take Drisdol and Macrobid together, and have interactions are studied.

Drisdol and Macrobid drug interactions.

What are the common drug interactions of Drisdol and Macrobid, by gender? *:

female:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  4. Essential hypertension (primary hypertension)
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Hydronephrosis (water inside the kidney)
  7. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  8. Hypokalaemia (low potassium)
  9. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

male:

n/a

What are the common drug interactions of Drisdol and Macrobid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain lower
  2. Anaemia (lack of blood)
  3. Bladder hypertrophy (bladder overgrowth- increase in cell size)
  4. Cardiomyopathy (weakening of the heart muscle)
  5. Chronic kidney disease
  6. Delirium (wild excitement)
  7. Detrusor sphincter dyssynergia (lack of external sphincter relaxation during voluntary voiding)
  8. Device related infection
  9. Escherichia sepsis (bacterial infection by escherichia coli)
  10. Escherichia urinary tract infection (urinary tract infection by escherichia coli)

40-49:

n/a

50-59:

  1. Carcinoid tumour pulmonary (slow growing tumour)
  2. Dyslipidaemia (abnormal amount of lipids)
  3. Dyspnoea (difficult or laboured respiration)
  4. Hypertension (high blood pressure)
  5. Hypertriglyceridaemia (excess of triglycerides in the blood)
  6. Lung neoplasm malignant (cancer tumour of lung)
  7. Obesity (having too much body fat)
  8. Renal failure (kidney dysfunction)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Chronic kidney disease
  2. Dry skin
  3. Skin swelling
  4. Swelling
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. Wheezing (a high-pitched whistling sound made while you breath)
  8. Abdominal discomfort
  9. Abdominal pain upper
  10. Cardiogenic shock (inadequate circulation of blood)

What are the existing conditions these people have? *

  1. Asthma: 6 people, 40.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 33.33%
  3. Muscle Spasms (muscle contraction): 4 people, 26.67%
  4. Anaemia (lack of blood): 3 people, 20.00%
  5. Infection: 3 people, 20.00%
  6. Gout (uric acid crystals building up in the body): 3 people, 20.00%
  7. Blood Pressure Abnormal: 2 people, 13.33%
  8. Cardiac Disorder: 2 people, 13.33%
  9. Dyspnea (difficult or laboured breathing): 2 people, 13.33%
  10. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Drisdol and Macrobid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Drisdol and Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Drisdol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Drisdol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macrobid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ergocalciferol and nitrofurantoin; nitrofurantoin, macrocrystalline (the active ingredients of Drisdol and Macrobid, respectively), and Drisdol and Macrobid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: